Researchers have discovered a type of "molecular glue" that can be used to inhibit certain pathological protein interactions.

Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, today announced the addition of a new membrane protein workflow to ...

Google DeepMind has released TxGemma, a new suite of open-source language models built to support therapeutic development. The models are intended to improve tasks such as drug candidate assessment, ...

Nuclera, a Cambridge biotech accelerating protein expression and optimisation, has added a new membrane protein workflow to its benchtop eProtein Discovery™ system.

The gallbladder plays an important role in digestion but hasn’t received much attention in medical research. However, that’s starting to change. With advances in stem cell technology, scientists can ...

The development and spread of antibiotic resistance represents one of the greatest threats to global health. To overcome ...

A novel artificial intelligence (AI) tool has revealed how disease-linked proteins misfold into harmful structures, a key ...

Oncodesign Services, a contract research organization specializing in drug discovery and preclinical development, appointed Dr. Aidan Synnott as chief executive officer, to help strengthen its ...

Citrullination, a transformative protein post-translational modification, is gaining recognition for its wide-ranging impact ...

AMPLY, the company behind the proprietary AMPLYfolioAI platform, is accelerating the discovery of new medicines for complex ...

A new AI tool called RibbonFold is revolutionizing how scientists understand misfolded proteins linked to Alzheimer’s and Parkinson’s.

A team of researchers from the University of Wollongong (UOW) have discovered that a unique trio of medications could hold ...